Dr Duddy Duddy
| Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial | 2026 |
|
Dr Duddy Duddy
Dr Joseph Guadagno
| Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial | 2025 |
|
Dr Duddy Duddy
| Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK | 2024 |
|
Dr Kirstie Anderson
Dr Naomi Warren
Dr Duddy Duddy
Dr James Miller
| Delivering an advice and guidance service in neurology | 2022 |
|
Dr Duddy Duddy
| Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register | 2021 |
|
Hannah Lowes
Dr Angela Pyle
Dr Duddy Duddy
Professor Gavin Hudson
| Cell-free mitochondrial DNA in progressive multiple sclerosis | 2019 |
|
Dr Duddy Duddy
| A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation | 2018 |
|
Dr Duddy Duddy
| Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease | 2018 |
|
Dr Duddy Duddy
| The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction | 2017 |
|
James Chapman
Dr David Lewis-Smith
Dr Joseph Guadagno
Dr Duddy Duddy
| The Newcastle Experience of Anti-Mog Associated Disease | 2016 |
|
Dr Duddy Duddy
| The UK risk sharing scheme: Final 10 years analysis | 2016 |
|
Dr Duddy Duddy
| The UK risk-sharing scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis | 2016 |
|
Dr Duddy Duddy
| Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator | 2015 |
|
Dr Joseph Guadagno
Dr Duddy Duddy
Emerita Professor Julia Newton
| Exploring the association between fatigue and autonomic dysfunction in multiple sclerosis | 2015 |
|
Dr Matthew Alexander
Dr Duddy Duddy
Dacia Jones
Gill O'Neill
| The state of MS: treatment goals and challenges | 2015 |
|
